JPRN-UMIN000015057已完成未知
Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients. - Metabolic change by SGLT2 inhibitors.
Kitasato University School of Medicine,Endocrinology and Metabolism.0 个研究点目标入组 20 人开始时间: 2014年9月4日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. severe ketosis, diabetic coma, or before coma 2. before and not long after surgery,or patients with severe trauma 3. alcohol intake's excessive 4. patients who have a fever of 37.0 degrees or more 5. obvious infection 6. severe renal dysfunction or dialysis patients 7. patients with symptoms of urinary retention, difficulty urinating, anuria, or oliguria 8. severe liver dysfunction 9. patients with obvious active malignant tumor 10. women suspected of pregnancy or pregnant 11. patients with a history of use SGLT2 inhibitors
研究者
相似试验
尚未招募
Unknown
Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indicesdiabetes mellitusJPRN-UMIN000050228agoya University4,250
已完成
不适用
Effect of SGLT2 inhibitor on energy metabolism in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000024822Kyoto University Graduate School of Medicine100
尚未招募
不适用
Effects of a SGLT2 inhibitor on glucose metabolism and body composition in patients with type 2 diabetesType 2 diabetes mellitusJPRN-UMIN000015402Department of Diabetes and Endocrinology Kobe City Medical Center General Hospital30
已完成
4 期
Glucose absorption inhibitors given during insulin withdrawal in type 1 and type3c diabetesDiabetes mellitusISRCTN16404006niversity of Leicester12
进行中（未招募）
1 期
The REFORM TrialType 2 diabetes and Heart FailureEUCTR2014-002742-42-GBniversity of Dundee/ NHS Tayside56